Related Experiment Video
Updated: Jul 7, 2025

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
Preventive Therapies in Peripheral Arterial Disease
Aangi J Shah1, Nicholas Pavlatos1, Dinesh K Kalra2
1Department of Internal Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Peripheral artery disease (PAD) is a growing global health issue driven by lipoprotein-mediated inflammation. This review covers PAD
Area of Science:
- Cardiovascular Medicine
- Vascular Biology
- Public Health
Background:
- Atherosclerosis is now understood as an inflammatory process, not just cell proliferation.
- Peripheral artery disease (PAD) incidence and its associated healthcare burden are increasing globally.
- Lipoproteins and their remnants are key contributors to atherosclerotic plaque development.
Purpose of the Study:
- To review the epidemiology, pathophysiology, and clinical presentation of PAD.
- To highlight the critical need for understanding PAD given its significant global impact.
- To discuss therapeutic strategies for preventing adverse cardiovascular and limb events in PAD patients.
Main Methods:
- Literature review focusing on atherosclerosis and peripheral artery disease.
- Synthesis of current knowledge on PAD pathophysiology and clinical manifestations.
- Analysis of therapeutic approaches for managing PAD complications.
Main Results:
- PAD is linked to poor cardiovascular and limb outcomes.
- Understanding PAD's multifactorial nature is crucial for effective management.
- Established role of lipoproteins in atherosclerotic disease progression.
Conclusions:
- PAD represents a significant and escalating global health challenge.
- Comprehensive knowledge of PAD's epidemiology, pathophysiology, and presentation is essential.
- Therapeutic interventions are vital for mitigating major adverse events in PAD.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
10:50Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Preventive Healthcare Services
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...